Product
WO3970
1 clinical trial
1 indication
Indication
Primary Axillary HyperhidrosisClinical trial
Combined Randomized, Double-blind, Dose-confirming Phase 3a Study in Parallel Design to Assess the Efficacy and Safety of Topical 4-week Treatment With 1% GPB Cream vs Placebo and Open-label Phase 3b Study to Assess Long-term Efficacy and Safety in Patients With Primary Axillary Hyperhidrosis Treated With 1% GPB CreamStatus: Completed, Estimated PCD: 2021-11-02